<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02022150</url>
  </required_header>
  <id_info>
    <org_study_id>GAS-819-12/13-1</org_study_id>
    <nct_id>NCT02022150</nct_id>
  </id_info>
  <brief_title>Body Composition Analysis in Cirrhotic Undergoing Paracentesis</brief_title>
  <acronym>Paracentesis</acronym>
  <official_title>Body Composition Analysis in Cirrhotic Patients With Ascites Undergoing Paracentesis Paracentesis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Ascites is a frequent complication of liver cirrhosis, initial treatment consists on
      diuretics intake, however, as the disease progresses this complication becomes more severe,
      consequently other therapeutic options are used.

      Paracentesis is indicated when severe ascites is present and it should be accompanied by
      albumin infusion.

      Nutritional status is generally affected in patients with liver cirrhosis, even more patients
      with severe ascites show decreased energy intake due to gastric compression.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>December 2012</start_date>
  <completion_date type="Anticipated">December 2016</completion_date>
  <primary_completion_date type="Anticipated">December 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Body composition</measure>
    <time_frame>Baseline and 8 days post treatment</time_frame>
    <description>bioelectrical impedance vector analysis</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Liver Cirrhosis</condition>
  <condition>Ascites</condition>
  <arm_group>
    <arm_group_label>Body composition in paracentesis</arm_group_label>
    <description>Taking blood samples and bioelectrical impedance, Psychometric Hepatic Encephalopathy Score (PHES) and Critical Flicker Frequency (CFF) before and after paracentesis.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Body composition in paracentesis</intervention_name>
    <description>Takin blood samples and bioelectrical impedance measurmeent, Neuropsychological tests evaluation</description>
    <arm_group_label>Body composition in paracentesis</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        The cohort will be selected from the Liver Clinic, Department of Gastroenterology at a
        tertiary care center in Mexico
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Any genre.

          -  Age 18-70 years old.

          -  Diagnosis of liver cirrhosis of any etiology (documented by clinical, biochemical,
             radiological and / or biopsy.

          -  Presence of high volume ascites

          -  The signing of informed consent will be required for the inclusion of any patient.

        Exclusion Criteria:

          -  Hepatic encephalopathy grade III or IV. 2) liver transplantation.

          -  Congestive heart failure.

          -  Hemodialysis.

          -  Acute or chronic renal failure.

          -  Nephrotic syndrome with protein loss.

          -  Alcoholism active in the last 6 months.

          -  Pregnancy.

          -  upper gastrointestinal bleeding.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Aldo Torre, M.D, M.Sc.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Instituto Nacional de Nutrición y Ciencias Médicas &quot;Salvador Zubirán&quot;</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Aldo Torre, M.D. M.Sci</last_name>
    <phone>54870900</phone>
    <phone_ext>2709</phone_ext>
    <email>detoal@yahoo.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Instituto Nacional de Ciencias Médicas y Nutrición &quot;Salvador Zubirán&quot;</name>
      <address>
        <city>Mexico city</city>
        <state>D.F</state>
        <zip>14000</zip>
        <country>Mexico</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Aldo Torre, M.D., M.Sc.</last_name>
      <phone>54870900</phone>
      <phone_ext>2711</phone_ext>
      <email>detoal@yahoo.com</email>
    </contact>
    <investigator>
      <last_name>Aldo Torre, M.D, M.Sc.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Instituto Nacional de Ciencias Médicas y Nutrición &quot;Salvador Zubirán&quot;</name>
      <address>
        <city>Mexico city</city>
        <country>Mexico</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Aldo Torre, M.D, M.Sc.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Mexico</country>
  </location_countries>
  <verification_date>June 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 17, 2013</study_first_submitted>
  <study_first_submitted_qc>December 20, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 27, 2013</study_first_posted>
  <last_update_submitted>June 7, 2016</last_update_submitted>
  <last_update_submitted_qc>June 7, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 8, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran</investigator_affiliation>
    <investigator_full_name>ALDO TORRE DELGADILLO</investigator_full_name>
    <investigator_title>M.D. M.Sc</investigator_title>
  </responsible_party>
  <keyword>Paracentesis</keyword>
  <keyword>Liver Cirrhosis</keyword>
  <keyword>ascites</keyword>
  <keyword>body composition</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fibrosis</mesh_term>
    <mesh_term>Liver Cirrhosis</mesh_term>
    <mesh_term>Ascites</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

